Neutral
Cardiff Oncology (NASDAQ: CRDF) CFO awarded 486,650 stock options
Cardiff Oncology's CFO, Joshua B. Muntner, was granted 486,650 stock options with an exercise price of $1.58 per share, expiring on April 6, 2036. The...